Teva Pharmaceutical snaps six straight sessions of losses
Teva Pharmaceutical ( NYSE: TEVA) shares snapped six straight sessions of losses, as the stock closed 0.88% higher at $17.21 ...
BIOA DEADLINE REMINDER: BFA Law Reminds BioAge Investors of the Imminent March 10 Class Action Deadline
New York, New York-- (Newsfile Corp. - February 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...
TMDX REMINDER: BFA Law Reminds TransMedics Group Investors to Contact the Firm about Ongo-ing Securities Investigation
New York, New York-- (Newsfile Corp. - February 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
Specialty Generics Growth Trends and Business Opportunities, 2025-2033: Patent Expirations of Branded Drugs a Key Driver
Teva Pharmaceuticals Industries, Akorn Inc., Mylan N.V., Mallinckrodt, and Sandoz International GmbH Lead the Competition ...